ARCHIVES

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

This article is from The Cancer Letter archive.

Vol. 26 No. 22 | June 2, 2000

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program

July 3, 1981

New NIH Chief Splits with Predecessors, HEW Brass, Opposes “Balance,” Likes Cancer Program

October 24, 1975

DCBD Board Okays Concept for Animal Holding Recompetition

December 5, 1986

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

Imbruvica Improves PFS, OS In Phase III CLL Study

December 26, 2014

Rauscher Responds To Criticism

March 21, 1975